Shabnam Ahmed

561 total citations
8 papers, 464 citations indexed

About

Shabnam Ahmed is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Shabnam Ahmed has authored 8 papers receiving a total of 464 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 3 papers in Oncology and 3 papers in Cancer Research. Recurrent topics in Shabnam Ahmed's work include Cancer, Hypoxia, and Metabolism (3 papers), Bioactive Compounds and Antitumor Agents (2 papers) and Synthesis and biological activity (2 papers). Shabnam Ahmed is often cited by papers focused on Cancer, Hypoxia, and Metabolism (3 papers), Bioactive Compounds and Antitumor Agents (2 papers) and Synthesis and biological activity (2 papers). Shabnam Ahmed collaborates with scholars based in United States, Hungary and Russia. Shabnam Ahmed's co-authors include Karuppaiyah Selvendiran, M. Lakshmi Kuppusamy, Periannan Kuppusamy, Mahmood Khan, Brian K. Rivera, Simi Chacko, Kálmán Hideg, Tamás Kálai, Anna Bratasz and Alex Dayton and has published in prestigious journals such as Free Radical Biology and Medicine, Antioxidants and Redox Signaling and American Journal of Physiology-Cell Physiology.

In The Last Decade

Shabnam Ahmed

8 papers receiving 457 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Shabnam Ahmed United States	7	208	122	112	111	83	8	464
Matthew Sobo United States	7	274 1.3×	83 0.7×	58 0.5×	253 2.3×	9 0.1×	8	494
Fu-Ju Chou United States	17	356 1.7×	87 0.7×	233 2.1×	116 1.0×	56 0.7×	22	682
Angela Maria Di Francesco Italy	13	296 1.4×	63 0.5×	91 0.8×	207 1.9×	32 0.4×	25	567
Cristina Corno Italy	13	301 1.4×	32 0.3×	55 0.5×	109 1.0×	26 0.3×	26	445
Ilaria Caldarelli Italy	13	298 1.4×	59 0.5×	76 0.7×	150 1.4×	20 0.2×	15	504
Mona Joudi Mashhad Iran	5	297 1.4×	193 1.6×	176 1.6×	112 1.0×	34 0.4×	7	550
Raghupathy Vengoji United States	15	422 2.0×	82 0.7×	197 1.8×	242 2.2×	41 0.5×	21	679
Yongli Li China	14	765 3.7×	79 0.6×	557 5.0×	90 0.8×	32 0.4×	30	958
Riccardo Bazzoni Italy	12	416 2.0×	210 1.7×	203 1.8×	107 1.0×	35 0.4×	18	618
Haibo Lu China	12	171 0.8×	54 0.4×	117 1.0×	158 1.4×	61 0.7×	29	455

Countries citing papers authored by Shabnam Ahmed

Since Specialization

Citations

This map shows the geographic impact of Shabnam Ahmed's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shabnam Ahmed with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shabnam Ahmed more than expected).

Fields of papers citing papers by Shabnam Ahmed

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shabnam Ahmed. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shabnam Ahmed. The network helps show where Shabnam Ahmed may publish in the future.

Co-authorship network of co-authors of Shabnam Ahmed

This figure shows the co-authorship network connecting the top 25 collaborators of Shabnam Ahmed. A scholar is included among the top collaborators of Shabnam Ahmed based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shabnam Ahmed. Shabnam Ahmed is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

Selvendiran, Karuppaiyah, Shabnam Ahmed, Alex Dayton, et al.. (2011). HO-3867, a curcumin analog, sensitizes cisplatin-resistant ovarian carcinoma, leading to therapeutic synergy through STAT3 inhibition. Cancer Biology & Therapy. 12(9). 837–845. 59 indexed citations

Bognár, Balázs, Shabnam Ahmed, M. Lakshmi Kuppusamy, et al.. (2010). Synthesis and study of new paramagnetic and diamagnetic verapamil derivatives. Bioorganic & Medicinal Chemistry. 18(8). 2954–2963. 5 indexed citations

Parthasarathy, Sampath, Min Luo, Shabnam Ahmed, et al.. (2010). Reactive Oxygen Species Mediate Oxidized Low-Density Lipoprotein-Induced Inhibition of Oct-4 Expression and Endothelial Differentiation of Bone Marrow Stem Cells. Antioxidants and Redox Signaling. 13(12). 1845–1856. 22 indexed citations

Selvendiran, Karuppaiyah, Shabnam Ahmed, Alex Dayton, et al.. (2010). Safe and targeted anticancer efficacy of a novel class of antioxidant-conjugated difluorodiarylidenyl piperidones: Differential cytotoxicity in healthy and cancer cells. Free Radical Biology and Medicine. 48(9). 1228–1235. 60 indexed citations

Selvendiran, Karuppaiyah, M. Lakshmi Kuppusamy, Shabnam Ahmed, et al.. (2010). Oxygenation inhibits ovarian tumor growth by down-regulating STAT3 and cyclin-D1 expressions. Cancer Biology & Therapy. 10(4). 386–390. 36 indexed citations

Chacko, Simi, Shabnam Ahmed, Karuppaiyah Selvendiran, et al.. (2010). Hypoxic preconditioning induces the expression of prosurvival and proangiogenic markers in mesenchymal stem cells. American Journal of Physiology-Cell Physiology. 299(6). C1562–C1570. 158 indexed citations

Selvendiran, Karuppaiyah, Shabnam Ahmed, Alex Dayton, et al.. (2010). HO-3867, a Synthetic Compound, Inhibits the Migration and Invasion of Ovarian Carcinoma Cells through Downregulation of Fatty Acid Synthase and Focal Adhesion Kinase. Molecular Cancer Research. 8(9). 1188–1197. 48 indexed citations

Selvendiran, Karuppaiyah, Liyue Tong, Anna Bratasz, et al.. (2010). Anticancer Efficacy of a Difluorodiarylidenyl Piperidone (HO-3867) in Human Ovarian Cancer Cells and Tumor Xenografts. Molecular Cancer Therapeutics. 9(5). 1169–1179. 76 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact